UR Medicine Faculty
The University of Rochester Medical Faculty Group
(URMFG) consists of over 900 specialist and primary care providers spanning 19
departments.
URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner
Accountable Health Partners (AHP) is a network of
over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the
region. AHP offers a full range of care.
After graduating from Cornell University in 1987 and receiving her MD from the Yale University School of Medicine in1991, Dr. Richard completed neurology residency at the University of Rochester in 1995, followed by the NIH-funded fellowship training in Movement Disorders and Experimental Therapeuti...
After graduating from Cornell University in 1987 and receiving her MD from the Yale University School of Medicine in1991, Dr. Richard completed neurology residency at the University of Rochester in 1995, followed by the NIH-funded fellowship training in Movement Disorders and Experimental Therapeutics in 1997. She joined the faculty of the University of Rochester in 1997 and has been an integral part of the Department of Neurology's missions in clinical care, research and education. The recipient of the Senior Faculty Award in 2013, Dr. Richard is a Professor of Neurology and Psychiatry.
Dr. Richard provides neurological care for patients with Parkinson's disease and related conditions and her research program focuses on the psychiatric aspects of these illnesses. She is the author of numerous scientific articles, editorials and book chapters and has been the recipient of career development awards and research grants, including one from NIH to lead a multi-center clinical trial evaluating the treatment of depression in PD. Dr. Richard serves as a reviewer for scientific journals and served as a member of the NIH Adult Psychopathology and Disorders of Aging Study as well as chair for several research grant review committee meetings for the Michael J. Fox Foundation (MJFF) for Parkinson's disease Research. She served as the Senior Medical Advisor for MJFF, is a member of the scientific advisory board and was the recipient of the 2011 Langtson Award for her valued contributions to the foundation. She has given lectures and chaired workshops and symposia at national meetings including the American Academy of Neurology and The World Parkinson Congress. Dr. Richard's efforts have brought new clinical and research attention to the previously overlooked area of mood disturbances in PD. Dr. Richard is dedicated to medical education at every level of training and serves as a member of the medical student clerkship grading committee, a faculty preceptor for the neurology resident longitudinal care clinic, director of the psychiatry resident neurology lecture series and director of the movement disorders fellowship program.
Faculty Appointments
Professor (Part-Time)
-
Department of Neurology, Movement Disorders (SMD)
Professor (Part-Time)
-
Department of Psychiatry (SMD) - Joint
Credentials
Residency & Fellowship
Fellowship, Movement Disorders, University of Rochester Medical Center. 1995 - 1997
Residency, Neurology, University of Rochester Medical Center. 1992 - 1995
Internship, Internal Medicine, University of Rochester Medical Center. 1991 - 1992
Education
MD | Yale University School of Medicine.1991
Awards
Fellow of the American Academy of Neurology.2017
Department of Neurology Senior Faculty Award.2013
Langston Award, Michael J. Fox Foundation.2011
Elected Member, American Neurological Association.2005
Rock Sleyster Scholar (Psychiatry).1990
Presidential Scholar, Cornell University.1987
Cornell University, ALS Honor Society, President.1987
Cornell University, First Place, Public Speaking Competition.1987
Phi Kappa Phi Honor Society.1985
Research
Dr. Richard's clinical research is aimed at understanding the pathophysiology of and developing effective treatments (medical and surgical) through clinical trials for neurological and psychiatric aspects of movement disorders, with a particular emphasis on depression in Parkinson's disease.
Dr. Richard's clinical research is aimed at understanding the pathophysiology of and developing effective treatments (medical and surgical) through clinical trials for neurological and psychiatric aspects of movement disorders, with a particular emphasis on depression in Parkinson's disease.
Pontone GM, Dissanayaka N, Apostolova L, Brown RG, Dobkin R, Dujardin K, Friedman JH, Leentjens AFG, Lenze EJ, Marsh L, Mari L, Monchi O, Richard IH, Schrag A, Strafella AP, Vernaleo B, Weintraub D, Mari Z
NPJ Parkinson's disease.. 2020 June 26 (1):10. Epub 06/02/2020.
Pontone GM, Dissanayka N, Apostolova L, Brown RG, Dobkin R, Dujardin K, Friedman JH, Leentjens AFG, Lenze EJ, Marsh L, Mari L, Monchi O, Richard IH, Schrag A, Strafella AP, Vernaleo B, Weintraub D, Mari Z
Starkstein SE, Dragovic M, Dujardin K, Marsh L, Martinez-Martin P, Pontone GM, Richard IH, Weintraub D, Leentjens AF
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2014 December 22 (12):1410-7. Epub 11/05/2013.
Richard IH, Frank S, McDermott MP, Wang H, Justus AW, Ladonna KA, Kurlan R
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.. 2004 December 17 (4):201-7. Epub 1900 01 01.
Movement disorders : official journal of the Movement Disorder Society.. 2000 January 15 (1):24-9. Epub 1900 01 01.
Tourette's syndrome: presentation and treatment complexities
Richard, I.H.
Journal Watch Neurology. Comments on and review of Robertson, M.M. Tourette's syndrome, associated conditions and the complexities of treatment. Brain 2000;123:426-462. 2000; 2: 46.
Worsening of motor function in Parkinson's disease: "A-typical" response to "atypical" antipsychotic medications [Editorial].
Neurology.. 1998 May 50 (5):1366-73. Epub 1900 01 01.
Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease?
Richard, I.H.; Maughn, A.; Kurlan, R.
Mov Disord. 1998; 51: 155-157.
Anxiety and Parkinson's disease
Richard, I.H.; Schiffer, R.B.; Kurlan, R.
Journal of Neuropsychiatry and Clinical Neurosciences. 1998; 8: 383-392.
Low dose clozapine for the treatment of drug-induced psychosis in idiopathic Parkinson's disease: Results of the double-blind, placebo controlled PSYCLOPS trial
Friedman, J.H.; Comella, C.; Factor, S.; Kurlan, R.; Parsa, M.; Pfeiffer, R.; Richard, I.; Parkinson Study Group.
At URMC, we believe that patients should be empowered to make the right decisions regarding their
personal
healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all
aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying
star ratings for our providers along with anonymous patient comments on our website. This will help you make
better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used
to generate this vital information. Learn more about
our survey process.
Ratings
Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)
4.8 stars
Likelihood of recommending this care provider to others
4.9 stars
Explanations the care provider gave you about your problem or condition
4.9 stars
Care provider's efforts to include you in decisions about your care
4.8 stars
Concern the care provider showed for your questions or worries
4.8 stars
Patient Comments
5.0 stars
Everything was explained extremely detailed and clearly.
